A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies

NCT07415031 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

170

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: Adagrasib
DRUG: Pembrolizumab
DRUG: Cetuximab
DRUG: Pemetrexed
DRUG: Docetaxel
DRUG: Irinotecan
DRUG: Leucovorin
DRUG: Oxaliplatin
DRUG: Fluorouracil

Sponsor

Mirati Therapeutics Inc.